NCT05157646

Brief Summary

This study will explore the effect of mutation severity on exercise capacity. Through a better understanding of the association between mutation severity and exercise capacity, clinicians will be more able to predict a given patient's level of independent functioning based on their genes, which is essential information that patients' families want to know upon diagnosis.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 15, 2021

Completed
8 months until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

September 14, 2022

Status Verified

September 1, 2022

Enrollment Period

3 months

First QC Date

December 1, 2021

Last Update Submit

September 9, 2022

Conditions

Keywords

Exercise

Outcome Measures

Primary Outcomes (1)

  • Change in weekly mileage

    Participants will report their weekly mileage in a REDCap form

    baseline to 10 weeks

Study Arms (1)

Exercise trackers

EXPERIMENTAL

Fitbit physical activity trackers

Behavioral: Fitness tracker

Interventions

Fitness trackerBEHAVIORAL

Participants will be asked to wear a Fitbit fitness tracker and report their fitness activity to the study team

Exercise trackers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cystic fibrosis patient who has been tested positive for a CF mutation of class 1-5.
  • Part of the VCU cystic fibrosis program.
  • Above 18 years old.

You may not qualify if:

  • Has not been tested positive for a known CF mutation.
  • Not a part of the VCU cystic fibrosis program.
  • Cannot be under 18 years old.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

MeSH Terms

Conditions

Cystic FibrosisMotor Activity

Interventions

Fitness Trackers

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesBehavior

Intervention Hierarchy (Ancestors)

Diagnostic EquipmentEquipment and SuppliesWearable Electronic DevicesElectrical Equipment and Supplies

Study Officials

  • Nauman Chaudary, MD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2021

First Posted

December 15, 2021

Study Start

August 1, 2022

Primary Completion

November 1, 2022

Study Completion

November 1, 2022

Last Updated

September 14, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations